secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pasithea Therapeutics Corp. (KTTA)
CIK:        0001841330
Form:       8-K
Filed at:   2024-06-26T23:59:59+00:00
Accession:  0001213900-24-056205
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pasithea Therapeutics stockholders elect Dr. Emer Leahy as Class I director; ratify Marcum LLP as auditor
--------------------------------------------------------------------------------

- Dr. Emer Leahy elected as Class I director with 227,198 for, 27,223 withheld, 115,196 broker non-votes.
- Ratification of Marcum LLP as independent auditor approved: 333,986 for, 34,177 against, 1,454 abstain.
- Annual Meeting held June 26, 2024; quorum of 369,617 shares of 1,043,248 outstanding shares represented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024056205/0001213900-24-056205-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841330/000121390024056205/ea0208474-8k_pasithea.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-056205

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer